Found: 16
Select item for more details and to access through your institution.
Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4144, doi. 10.3390/ijms23084144
- By:
- Publication type:
- Article
Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1315, doi. 10.3390/biom12091315
- By:
- Publication type:
- Article
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1062, doi. 10.3390/cancers15041062
- By:
- Publication type:
- Article
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 897, doi. 10.3390/cancers15030897
- By:
- Publication type:
- Article
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133250
- By:
- Publication type:
- Article
Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4599, doi. 10.3390/cancers13184599
- By:
- Publication type:
- Article
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11035-6
- By:
- Publication type:
- Article
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 3972, doi. 10.1002/cam4.5240
- By:
- Publication type:
- Article
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1228907
- By:
- Publication type:
- Article
Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 5, p. 1036, doi. 10.1002/ijc.34356
- By:
- Publication type:
- Article
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 4, p. 1, doi. 10.1007/s00018-022-04226-0
- By:
- Publication type:
- Article
Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.84919
- By:
- Publication type:
- Article
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain (PRO‐C11) in patients with pancreatic ductal adenocarcinoma.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 228, doi. 10.1002/ijc.33551
- By:
- Publication type:
- Article
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 10, p. 2913, doi. 10.1002/ijc.32751
- By:
- Publication type:
- Article
Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 23, p. 3763, doi. 10.3390/cells11233763
- By:
- Publication type:
- Article
Prognostic impact of Charlson's Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer.
- Published in:
- European Journal of Cancer Care, 2020, v. 29, n. 3, p. 1, doi. 10.1111/ecc.13219
- By:
- Publication type:
- Article